Fig. 6From: Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer Validation of the prognostic signature based on 11 LRGs in GEO set. A Kaplan-Meier survival analysis of BLCA patients between high-risk groups and low-risk groups. B Time-independent receiver operating characteristic (ROC) analysis of risk scores predicting the overall survival. C Distribution of LRG-based risk score and different patterns of survival status and survival time between the high- and low-risk groupsBack to article page